Search research articles
Contact Us
Filters
Showing results (1-10 of 53) with videos related to
Page
of 6
Sort By:
Journal of Current Science and Technology
|
April 1, 2021
Perspective on the treatment of non-small cell lung cancer in the context of potential SARS-CoV-2 infection during the pandemic
George Theodoropoulos, Katerina Albanis, Medhi Wangpaichitr
Frontiers in Oncology
|
February 6, 2025
Targeting the kynurenine pathway: another therapeutic opportunity in the metabolic crosstalk between cancer and immune cells
Irene Kang, George Theodoropoulos, Medhi Wangpaichitr
Water Research
|
December 28, 2002
Evaluation of granular activated carbon technology for the removal of methyl tertiary butyl ether (MTBE) from drinking water
Tom C Shih, Medhi Wangpaichitr, Mel Suffet
Journal of Personalized Medicine
|
February 25, 2025
Targeting Metabolic Vulnerabilities to Combat Drug Resistance in Cancer Therapy
Taranatee Khan, Manojavan Nagarajan, Irene Kang, et al.
Reviews in Endocrine & Metabolic Disorders
|
November 26, 2024
The development of growth hormone-releasing hormone analogs: Therapeutic advances in cancer, regenerative medicine, and metabolic disorders
Andrew V Schally, Renzhi Cai, Xianyang Zhang, et al.
Angewandte Chemie (International Ed. in English)
|
December 13, 2017
A Kinetic Dearomatization Strategy for an Expedient Biomimetic Route to the Bielschowskysin Skeleton
Paul Scesa, Medhi Wangpaichitr, Niramol Savaraj, et al.
Molecular Cancer Therapeutics
|
June 21, 2008
Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-D-glucose under hypoxia in lung cancer cell lines
Medhi Wangpaichitr, Niramol Savaraj, Johnathan Maher, et al.
The Indian Journal of Radiology & Imaging
|
April 16, 2016
Radiofrequency ablation in primary non-small cell lung cancer: What a radiologist needs to know
Shivank Bhatia, Keith Pereira, Prasoon Mohan, et al.
Molecular Cancer Therapeutics
|
February 20, 2007
Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose
Johnathan C Maher, Medhi Wangpaichitr, Niramol Savaraj, et al.
BMC Cancer
|
July 25, 2024
AT-0174, a novel dual IDO1/TDO2 enzyme inhibitor, synergises with temozolomide to improve survival in an orthotopic mouse model of glioblastoma
Michael J Bickerdike, Imane Nafia, Alban Bessede, et al.
Page
of 6
Search research articles
Search
Showing results (1-10 of 53) with videos related to
Sort By:
Page
of 6
Journal of Current Science and Technology
|
April 1, 2021
Perspective on the treatment of non-small cell lung cancer in the context of potential SARS-CoV-2 infection during the pandemic
George Theodoropoulos, Katerina Albanis, Medhi Wangpaichitr
Frontiers in Oncology
|
February 6, 2025
Targeting the kynurenine pathway: another therapeutic opportunity in the metabolic crosstalk between cancer and immune cells
Irene Kang, George Theodoropoulos, Medhi Wangpaichitr
Water Research
|
December 28, 2002
Evaluation of granular activated carbon technology for the removal of methyl tertiary butyl ether (MTBE) from drinking water
Tom C Shih, Medhi Wangpaichitr, Mel Suffet
Journal of Personalized Medicine
|
February 25, 2025
Targeting Metabolic Vulnerabilities to Combat Drug Resistance in Cancer Therapy
Taranatee Khan, Manojavan Nagarajan, Irene Kang, et al.
Reviews in Endocrine & Metabolic Disorders
|
November 26, 2024
The development of growth hormone-releasing hormone analogs: Therapeutic advances in cancer, regenerative medicine, and metabolic disorders
Andrew V Schally, Renzhi Cai, Xianyang Zhang, et al.
Angewandte Chemie (International Ed. in English)
|
December 13, 2017
A Kinetic Dearomatization Strategy for an Expedient Biomimetic Route to the Bielschowskysin Skeleton
Paul Scesa, Medhi Wangpaichitr, Niramol Savaraj, et al.
Molecular Cancer Therapeutics
|
June 21, 2008
Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-D-glucose under hypoxia in lung cancer cell lines
Medhi Wangpaichitr, Niramol Savaraj, Johnathan Maher, et al.
The Indian Journal of Radiology & Imaging
|
April 16, 2016
Radiofrequency ablation in primary non-small cell lung cancer: What a radiologist needs to know
Shivank Bhatia, Keith Pereira, Prasoon Mohan, et al.
Molecular Cancer Therapeutics
|
February 20, 2007
Hypoxia-inducible factor-1 confers resistance to the glycolytic inhibitor 2-deoxy-D-glucose
Johnathan C Maher, Medhi Wangpaichitr, Niramol Savaraj, et al.
BMC Cancer
|
July 25, 2024
AT-0174, a novel dual IDO1/TDO2 enzyme inhibitor, synergises with temozolomide to improve survival in an orthotopic mouse model of glioblastoma
Michael J Bickerdike, Imane Nafia, Alban Bessede, et al.
Page
of 6